Long-circulating liposomal prednisolone versus pulse intramuscular methylprednisolone in patients with active rheumatoid arthritis

Trial Profile

Long-circulating liposomal prednisolone versus pulse intramuscular methylprednisolone in patients with active rheumatoid arthritis

Completed
Phase of Trial: Phase I/II

Latest Information Update: 27 Oct 2008

At a glance

  • Drugs Prednisolone (Primary) ; Methylprednisolone
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Oct 2008 Secondary endpoint 'Clinical response' has been met, according to a Galapagos NV media release.
    • 28 May 2008 The expected completion date for this trial is now 1 May 2008, according to ClinicalTrials.gov.
    • 28 May 2008 Status changed from recruiting to completed, reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top